Diana R. Kerwin
Expertise in
2
conditions

Dr. Diana R. Kerwin

Geriatrics | Internal Medicine
Texas Health Resources
Kerwin Research Center & Memory Care
8198 Walnut Hill Ln, Ste 100, 
Dallas, TX 
On Staff At
Expertise in
2
conditions
Texas Health Resources
Kerwin Research Center & Memory Care
8198 Walnut Hill Ln, Ste 100, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Diana Kerwin is an Internal Medicine specialist and a Geriatrics provider in Dallas, Texas. Dr. Kerwin is highly rated in 2 conditions, according to our data. Her top areas of expertise are Dementia, Alzheimer's Disease, Lewy Body Dementia (LBD), and Vascular Dementia.

Her clinical research consists of co-authoring 39 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Medical College Of Wisconsin School Of Medicine - Registrar (1996)
Residency
Northwestern University/Feinberg School of Medicine - Medicine (1999)
Specialties
Geriatrics
Internal Medicine
Licenses
Geriatric Medicine in WI
Fellowships
Northwestern University/Feinberg School of Medicine - Geriatric (2000)
Hospital Affiliations
Texas Health Dallas
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Kerwin Research Center & Memory Care
8198 Walnut Hill Ln, Ste 100, Dallas, TX 75231
Call: 972-433-9100

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2025
Intervention Type: Drug
Study Drugs: Gantenerumab, Solanezumab
Study Phase: Phase 2/Phase 3
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Drug
Study Drug: LY3372689
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2/Phase 3
A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease
A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Drug
Study Drugs: Donanemab, Aducanumab
Study Phase: Phase 3
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 23, 2023
Intervention Type: Drug
Study Drug: COR388
Study Phase: Phase 2/Phase 3
Development of a Biomarker Database to Investigate Aß, P-tau, and NfL Blood-Based Biomarkers and Digital Biomarkers in Older Participants Screened for Preclinical Alzheimer's Disease (AD), Prodromal AD, or Mild AD
Development of a Biomarker Database to Investigate Aß, P-tau, and NfL Blood-Based Biomarkers and Digital Biomarkers in Older Participants Screened for Preclinical Alzheimer's Disease (AD), Prodromal AD, or Mild AD
Enrollment Status: Completed
Publish Date: February 09, 2023
Intervention Type: Other
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Drug
Study Drug: Tilavonemab
Study Phase: Phase 2
Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2
Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2
Enrollment Status: Completed
Publish Date: May 21, 2021
18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia
18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia
Enrollment Status: Completed
Publish Date: September 25, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 1
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 11 Less Clinical Trials

39 Total Publications

A Functional Resting-State Network Atlas Based on 420 Older Adults with Hypertension.
A Functional Resting-State Network Atlas Based on 420 Older Adults with Hypertension.
Journal: bioRxiv : the preprint server for biology
Published: December 11, 2025
View All 39 Publications
Similar Doctors
Expertise in
60
conditions
Dr. Soroush Behnam
Geriatrics | Internal Medicine
Expertise in
60
conditions
Dr. Soroush Behnam
Geriatrics | Internal Medicine

Dallas Medical Specialists, PLLC

7777 Forest Ln, Suite C300, 
Dallas, TX 
 (3.1 miles away)
972-566-6000
Languages Spoken:
English, Bengali, Farsi, German, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Soroush Behnam is a primary care provider, practicing in Geriatrics and Internal Medicine in Dallas, Texas. Dr. Behnam is highly rated in 60 conditions, according to our data. His top areas of expertise are Acute Cystitis, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Low Sodium Level. Dr. Behnam is currently accepting new patients.

Expertise in
2
conditions
Dr. Joseph H. Flaherty
Geriatrics | Internal Medicine
Expertise in
2
conditions
Dr. Joseph H. Flaherty
Geriatrics | Internal Medicine

Questcare Matrix PLLC

3901 W 15th St, 
Plano, TX 
 (10.3 miles away)
954-939-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Flaherty is a primary care provider, practicing in Geriatrics and Internal Medicine in Plano, Texas. Dr. Flaherty is highly rated in 2 conditions, according to our data. His top areas of expertise are Delirium, Dementia, Cerebellar Degeneration, and Acute Kidney Failure. Dr. Flaherty is currently accepting new patients.

Expertise in
16
conditions
Dr. Maria P. Ambalong
Geriatrics | Family Medicine
Expertise in
16
conditions
Dr. Maria P. Ambalong
Geriatrics | Family Medicine

Texas Health Physicians Group

9250 Amberton Pkwy, 
Dallas, TX 
 (3.1 miles away)
214-860-6600
Languages Spoken:
English
See accepted insurances

Maria Ambalong is a primary care provider, practicing in Geriatrics and Family Medicine in Dallas, Texas. Dr. Ambalong is highly rated in 16 conditions, according to our data. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Dementia.

VIEW MORE Geriatricians

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kerwin's expertise for a condition
ConditionClose
    • Distinguished
    • Dementia
      Dr. Kerwin is
      Distinguished
      . Learn about Dementia.
      See more Dementia experts
    • Advanced
    • Alzheimer's Disease
      Dr. Kerwin is
      Advanced
      . Learn about Alzheimer's Disease.
      See more Alzheimer's Disease experts
    • Experienced
    • Cerebellar Degeneration
      Dr. Kerwin is
      Experienced
      . Learn about Cerebellar Degeneration.
      See more Cerebellar Degeneration experts
    • Lewy Body Dementia (LBD)
      Dr. Kerwin is
      Experienced
      . Learn about Lewy Body Dementia (LBD).
      See more Lewy Body Dementia (LBD) experts
    • Vascular Dementia
      Dr. Kerwin is
      Experienced
      . Learn about Vascular Dementia.
      See more Vascular Dementia experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Geriatricians Dallas, TX
    3. Dr. Diana R. Kerwin
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.